Anti-Angiogenic Cancer Therapy Based on Integrin v&bgr;3 Antagonism

E-ISSN： 1875-5992|6|5|407-428

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.6, Iss.5, 2006-09, pp. : 407-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Integrin v&bgr;3 Antagonists for Anti-Angiogenic Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 143-158

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Therapy as a Cancer Treatment Paradigm

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 115-130

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic therapy for osteosarcoma

By Quan Gerald

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 707-713

Springer Publishing Company

Access to resources Recommend Favorite

The emerging role of anti-angiogenic therapy in ovarian cancer (Review)

By Conteduca Vincenza Kopf Barbara Burgio Salvatore Luca Bianchi Emanuela Amadori Dino De Giorgi Ugo

International Journal of Oncology, Vol. 44, Iss. 5, 2014-05 ,pp. : 1417-1424

Spandidos Publications

Access to resources Recommend Favorite

Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-11 ,pp. : 1071-1080

Bentham Science Publishers

Access to resources Recommend Favorite